These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26768736)

  • 1. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.
    Nielsen S; Van Hout MC
    Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom.
    Tobin CL; Dobbin M; McAvoy B
    Aust N Z J Public Health; 2013 Oct; 37(5):483-8. PubMed ID: 24090333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
    Van Hout MC; Norman I
    Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine?
    Parry CD; Deluca P; Cooper R; Van Hout MC
    Addiction; 2015 Oct; 110(10):1690-1. PubMed ID: 26250941
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
    Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk.
    Wells JS; Bergin M; Van Hout MC; McGuinness P; De Pleissisc J; Rich E; Dada S; Wells R; Gooney MA
    J Pharm Pharm Sci; 2018; 21(1):30049. PubMed ID: 30011259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
    Cairns R; Brown JA; Buckley NA
    Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best Practices and Innovations for Managing Codeine Misuse and Dependence.
    Norman IJ; Bergin M; Parry CD; Van Hout MC
    J Pharm Pharm Sci; 2016; 19(3):367-381. PubMed ID: 27806253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand.
    McAvoy BR; Dobbin MD; Tobin CL
    N Z Med J; 2011 Nov; 124(1346):29-33. PubMed ID: 22143850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.
    Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L
    Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counting the cost of over-the-counter codeine containing analgesic misuse: A retrospective review of hospital admissions over a 5 year period.
    Mill D; Johnson JL; Cock V; Monaghan E; Hotham ED
    Drug Alcohol Rev; 2018 Feb; 37(2):247-256. PubMed ID: 28925091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey.
    Kimergård A; Foley M; Davey Z; Dunne J; Drummond C; Deluca P
    QJM; 2017 Sep; 110(9):559-564. PubMed ID: 28379496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013-2019: A Retrospective Observational Study.
    Richards GC; Aronson JK; MacKenna B; Goldacre B; Hobbs FDR; Heneghan C
    Drug Saf; 2022 Mar; 45(3):237-247. PubMed ID: 35066803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective.
    Nielsen S; Cameron J; Pahoki S
    Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse.
    Lo MY; Ong MW; Lin JG; Sun WZ
    Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):135-8. PubMed ID: 26646544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-the-counter and prescription medicine misuse in Cape Town--findings from specialist treatment centres.
    Myers B; Siegfried N; Parry CD
    S Afr Med J; 2003 May; 93(5):367-70. PubMed ID: 12830601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists.
    Hamer AM; Spark MJ; Wood PJ; Roberts E
    Res Social Adm Pharm; 2014; 10(4):669-78. PubMed ID: 24144932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-the-counter codeine use in Iceland: the impact of increased access.
    Almarsdóttir AB; Grimsson A
    Scand J Public Health; 2000 Dec; 28(4):270-4. PubMed ID: 11228114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a clinical tool to assess and address pain management requests in the pharmacy.
    Wood P; Tucci J; Anderson K; Mnatzaganian G
    Res Social Adm Pharm; 2019 Jul; 15(7):852-857. PubMed ID: 30611648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.